William S Bradham1, Susan P Bell1, Douglas W Adkisson1, Holly M Smith1, Frank E Harrell1, Mark A Lawson1, Henry Ooi1, Douglas B Sawyer1, Marvin W Kronenberg2. 1. Division of Cardiovascular Medicine and Department of Biostatistics, Vanderbilt University School of Medicine and the Cardiology Section, Veterans Administration Tennessee Valley Healthcare System, Nashville, Tennessee. 2. Division of Cardiovascular Medicine and Department of Biostatistics, Vanderbilt University School of Medicine and the Cardiology Section, Veterans Administration Tennessee Valley Healthcare System, Nashville, Tennessee. Electronic address: marvin.w.kronenberg@vanderbilt.edu.
Abstract
BACKGROUND: The myocardial longitudinal relaxation time (T1) on cardiac magnetic resonance imaging (CMR) can quantify myocardial fibrosis in the presence or absence of visually detectable late gadolinium (Gd) enhancement (LGE). Mineralocorticoid receptor antagonist (MRA) treatment produces beneficial remodeling in nonischemic dilated cardiomyopathy (NIDCM). We assessed the hypothesis that interstitial myocardial fibrosis measured with the use of CMR predicts left ventricular (LV) beneficial remodeling in NIDCM after heart failure (HF) treatment including MRAs. METHODS AND RESULTS: Twelve patients with NIDCM, on stable beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor-blocking therapy, were studied before and after 6-29 months of treatment with MRAs, by means of CMR assessment of LV structure, function, and T1 from standard Look-Locker sequences (T1LL). All patients had depressed cardiac function, dilated left ventricles, and no visual LGE. After adding MRA to HF treatment, the LV ejection fraction increased and the LV end-systolic volume index (LV end-systolic volume/m2) decreased in all patients (P < .0001). This this was inversely proportional to the baseline myocardial T1LL (r = -0.65; P = .02). CONCLUSION: Myocardial T1LL, in the absence of visually detectable LGE, was quantitatively related to the degree of beneficial LV remodeling achieved in response to adding MRA to a HF regimen. Published by Elsevier Inc.
BACKGROUND: The myocardial longitudinal relaxation time (T1) on cardiac magnetic resonance imaging (CMR) can quantify myocardial fibrosis in the presence or absence of visually detectable late gadolinium (Gd) enhancement (LGE). Mineralocorticoid receptor antagonist (MRA) treatment produces beneficial remodeling in nonischemic dilated cardiomyopathy (NIDCM). We assessed the hypothesis that interstitial myocardial fibrosis measured with the use of CMR predicts left ventricular (LV) beneficial remodeling in NIDCM after heart failure (HF) treatment including MRAs. METHODS AND RESULTS: Twelve patients with NIDCM, on stable beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor-blocking therapy, were studied before and after 6-29 months of treatment with MRAs, by means of CMR assessment of LV structure, function, and T1 from standard Look-Locker sequences (T1LL). All patients had depressed cardiac function, dilated left ventricles, and no visual LGE. After adding MRA to HF treatment, the LV ejection fraction increased and the LV end-systolic volume index (LV end-systolic volume/m2) decreased in all patients (P < .0001). This this was inversely proportional to the baseline myocardial T1LL (r = -0.65; P = .02). CONCLUSION: Myocardial T1LL, in the absence of visually detectable LGE, was quantitatively related to the degree of beneficial LV remodeling achieved in response to adding MRA to a HF regimen. Published by Elsevier Inc.
Entities:
Keywords:
Cardiac magnetic resonance imaging; heart failure; myocardial fibrosis
Authors: Marcelo Souto Nacif; Evrim B Turkbey; Neville Gai; Saman Nazarian; Rob J van der Geest; Radwa A Noureldin; Christopher T Sibley; Martin Ugander; Songtao Liu; Andrew E Arai; João A C Lima; David A Bluemke Journal: J Magn Reson Imaging Date: 2011-09-23 Impact factor: 4.813
Authors: Daniel R Messroghli; Sven Plein; David M Higgins; Kevin Walters; Timothy R Jones; John P Ridgway; Mohan U Sivananthan Journal: Radiology Date: 2006-01-19 Impact factor: 11.105
Authors: Daniel R Messroghli; Andre Rudolph; Hassan Abdel-Aty; Ralf Wassmuth; Titus Kühne; Rainer Dietz; Jeanette Schulz-Menger Journal: BMC Med Imaging Date: 2010-07-30 Impact factor: 1.930
Authors: Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke Journal: Radiology Date: 2012-10-22 Impact factor: 11.105
Authors: J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell Journal: Circulation Date: 2003-06-23 Impact factor: 29.690
Authors: Mark A Lawson; David E Hansen; Deepak K Gupta; Susan P Bell; Douglas W Adkisson; Ravinder R Mallugari; Douglas B Sawyer; Henry Ooi; Marvin W Kronenberg Journal: ESC Heart Fail Date: 2021-01-05